Carcinoma, Bronchogenic
Showing 1 - 25 of 7,670
LUng CAncer focuS - Long-term Monitoring of Bronchogenic
Recruiting
- Lung Cancer
-
Brno, Czechia
- +6 more
Mar 7, 2022
Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)
Recruiting
- Bronchial Cancer
-
Strasbourg, FranceService de chirurgie thoracique - CHU de Strasbourg - France
Oct 28, 2022
Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1
Recruiting
- Lung Cancer
- +11 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Anqing, Anhui, ChinaThe PLA Navy Anqing Hospital
May 23, 2023
Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)
Recruiting
- Lung Neoplasm Malignant
- +18 more
-
Fairfax, VirginiaNew Experimental Therapeutics of Virginia (NEXT Oncology)
Mar 29, 2022
NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)
Recruiting
- Non-Small Cell Lung Cancer
- +14 more
-
Glendale, California
- +12 more
Feb 2, 2023
Effectiveness of Care in Certified Cancer Centres in Germany
Completed
- Colorectal Cancer
- +9 more
- Oncological certification
-
Dresden, Sachsen, GermanyTechnische Universität Dresden
Aug 22, 2022
Immunotherapy Plus Chemotherapy Administration to Bronchial
Recruiting
- Bronchial Cancer
- home-based hospitalization
-
Pau, Aquitaine, FranceCentre hospitalier de pau
Sep 30, 2021
Bronchial Cancer Trial in Paris (ISET® - Isolation by Size of Tumor cells)
Completed
- Bronchial Cancer
- ISET® - Isolation by Size of Tumor cells
-
Paris, Ile-de-France, FranceGroupe Hospitalier Paris Saint Joseph
Aug 20, 2021
Pralsetinib to Best Available Therapy in RET-Fusion Positive
Enrolling by invitation
- RET-fusion Non Small Cell Lung Cancer
- +16 more
-
New York, New York
- +2 more
Aug 9, 2021
NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)
Recruiting
- Non-Small Cell Lung Cancer
- +13 more
- furmonertinib 240 mg
- +2 more
-
Yuma, Arizona
- +37 more
Dec 14, 2022
Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and
Recruiting
- HNSCC
- +6 more
- Conventional Therapy acc. to prevailing clincal approved schemes
-
Erlangen, Bavaria, GermanyDepartment of Radiation Oncology, Universitätsklinikum Erlangen
May 18, 2021
Breast Cancer, Gynecologic Cancer, Bronchial Cancer Trial in Bron, Lyon, Pierre-Bénite (CANUT support, Anthropometric measures,
Recruiting
- Breast Cancer
- +3 more
- CANUT support
- +10 more
-
Bron, France
- +6 more
Mar 2, 2022
Immunotherapy Administration to Bronchial Cancer inHospital-at-
Completed
- Bronchial Cancer
-
Pau, Aquitaine, FranceCentre hospitalier de pau
Jan 20, 2021
Lung Cancer Trial in Cairo (bronchoscpe)
Completed
- Lung Cancer
- bronchoscpe
-
Cairo, EgyptBenha University Hospital- Chest Department
Nov 27, 2021
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
Non Small Cell Lung Cancer, Non-Small Cell Carcinoma of Lung, TNM Stage 4, Bronchogenic Cancer Trial (cryotherapy)
Completed
- Non Small Cell Lung Cancer
- +2 more
- cryotherapy
- (no location specified)
Mar 4, 2021
Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Shanghai (SHR-1210, Carboplatin, Pemetrexed)
Completed
- Lung Neoplasms
- +8 more
- SHR-1210
- +2 more
-
Shanghai, Shanghai, ChinaTongji University, Shanghai Pulmonary Hospital
Jun 7, 2020
Bronchial Carcinoma, Esophageal Carcinoma, Tumor of the Brain Trial in Tübingen (Fitness tracker based activity training for Arm
Recruiting
- Bronchial Carcinoma
- +6 more
- Fitness tracker based activity training for Arm A and B. Booklet "physical training, exercise and cancer" and an introduction about physical activity during cancer therapy for Arm A, B, C
-
Tübingen, Baden-Württemberg, GermanyUniversity Hospital Tübingen
Aug 13, 2020
Lung Tumors, Thoracic Surgery, NSCLC Trial in Shanghai (Subxiphoid uniportal VATS, Intercostal uniportal VATS)
Completed
- Lung Neoplasms
- +5 more
- Subxiphoid uniportal VATS
- Intercostal uniportal VATS
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Feb 28, 2020
NSCLC Metastatic Trial in Dijon (CTC)
Terminated
- Non-small Cell Lung Cancer Metastatic
- CTC
-
Dijon, FranceCentre Georges François Leclerc
Jan 24, 2020
Advanced or Metastatic NSCLC Trial in Moscow, Saint Petersburg, St. Petersburg (Ceralasertib, Durvalumab)
Recruiting
- Advanced or Metastatic NSCLC
-
Moscow, Russian Federation
- +7 more
Jul 4, 2023